Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of COVID‐19 Among Unvaccinated and Vaccinated Patients With Rheumatoid Arthritis: A General Population Study
Hui Li, Zachary S. Wallace, Jeffrey A. Sparks, et al.
Arthritis Care & Research (2022) Vol. 75, Iss. 5, pp. 956-966
Open Access | Times Cited: 20

Showing 20 citing articles:

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
Grace Qian, Xiaosong Wang, Naomi J. Patel, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 3, pp. e139-e150
Open Access | Times Cited: 43
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic
Alessandra Zaccardelli, Zachary S. Wallace, Jeffrey A. Sparks
Current Opinion in Rheumatology (2023) Vol. 35, Iss. 3, pp. 175-184
Open Access | Times Cited: 11
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study
Hilde S Ørbo, K. H. Bjørlykke, Joseph Sexton, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e003545-e003545
Open Access | Times Cited: 3
Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study
Xiaofeng Jiang, Jeffrey A. Sparks, Zachary S. Wallace, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002839-e002839
Open Access | Times Cited: 9
Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study
Vasiliki-Kalliopi Bournia, G. Fragoulis, Panagiota Mitrou, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 4, pp. 1130-1138
Open Access | Times Cited: 9
Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study
Emily Kowalski, Xiaosong Wang, Naomi J. Patel, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 63, pp. 152286-152286
Closed Access | Times Cited: 7
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study
C. Sieiro Santos, J. P. Chen, Elena Nikiphorou, et al.
Rheumatology International (2024) Vol. 44, Iss. 5, pp. 805-817
Closed Access | Times Cited: 2
The impact of SARS-CoV-2 infection and vaccination on inflammatory arthritis: a cohort study
Giovanni Striani, Ariela Hoxha, Mariagrazia Lorenzin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
Andrea Picchianti Diamanti, Assunta Navarra, Alessandra Aiello, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1684-1684
Open Access | Times Cited: 4
Autoimmune rheumatic diseases and COVID-19 vaccination: a retrospective cross-sectional study from Astana
Kristina Rutskaya-Moroshan, Saule Abisheva, Madina Sarsenova, et al.
Reumatologia/Rheumatology (2024) Vol. 62, Iss. 1, pp. 26-34
Open Access | Times Cited: 1
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study
Abigail E. Schiff, Xiaosong Wang, Naomi J. Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study
Grace Qian, Xiaosong Wang, Naomi J. Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Impact of the COVID-19 Pandemic on People Living with Rheumatoid Arthritis: Experiences and Preferences in Accessing Healthcare Across Five Countries
Alain Saraux, Lícia Maria Henrique da Mota, Sanjay Dixit, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 2, pp. 257-268
Open Access
Rheumatoide Arthritis: COVID-19-Risiko mit und ohne Impfung

Aktuelle Rheumatologie (2024) Vol. 49, Iss. 01, pp. 14-16
Closed Access
Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting
María Torres-Rufas, Esther F. Vicente‐Rabaneda, Laura Cardeñoso, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 672-672
Open Access
Rheumatoid arthritis and COVID-19 outcomes: a systematic review and Meta-analysis
Liang Jin, Jen Ling Gan, Xuewei Li, et al.
BMC Rheumatology (2024) Vol. 8, Iss. 1
Open Access
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
Hilde S Ørbo, Taissa de Matos Kasahara, Asia‐Sophia Wolf, et al.
The Lancet Regional Health - Europe (2024) Vol. 48, pp. 101121-101121
Closed Access
Rheumatoid arthritis and COVID-19: Three years later
Б. С. Белов, E. S. Aronova, Г. И. Гриднева, et al.
Rheumatology Science and Practice (2023) Vol. 61, Iss. 4, pp. 450-457
Open Access | Times Cited: 1
Understanding COVID-19 vaccine hesitancy in vasculitis patients
Imama N. Butt, Charmaine van Eeden, Katharina Kovacs Burns, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access
Page 1

Scroll to top